Research And Markets: Transdermal And Transmucosal Drug Delivery Market Is Thought To Grow Up To $10 Billion By 2010.DUBLIN, Ireland -- Delivering drugs non-invasively through the skin, and particularly through the mucosa in the oral cavity oral cavity n. The part of the mouth behind the teeth and gums that is bounded above by the hard and soft palates and below by the tongue and the mucous membrane connecting it with the inner part of the mandible. or nose, has grown from a specialized application field to a formulation option that is not only convenient for the patient but also combines sustained or flash delivery with improved metabolic profile. Research and Markets (http://www.researchandmarkets.com/reports/c8107) has announced the addition of Transdermal and Transmucosal Therapeutics - New Developments in Drug Delivery to their offering. While transdermal and transmucosal drug delivery had mainly focused on smoking cessation smoking cessation Public health Temporary or permanent halting of habitual cigarette smoking; withdrawal therapies–eg, hypnosis, psychotherapy, group counseling, exposing smokers to Pts with terminal lung CA and nicotine chewing gum are often ineffective. and cancer pain a few years ago, the therapeutic scope has since dramatically expanded to include contraception, sexual dysfunction sexual dysfunction Inability to experience arousal or achieve sexual satisfaction under ordinary circumstances, as a result of psychological or physiological problems. , alcohol abuse, attention deficit disorder attention deficit (hyperactivity) disorder (ADD or ADHD) formerly hyperactivity Behavioral syndrome in children, whose major symptoms are inattention and distractibility, restlessness, inability to sit still, and difficulty concentrating on one thing for any , and Parkinson's disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. , among others. In addition, new chemical entities are now being specifically tailored for this route of administration as a competitive marketing strategy. Transdermal and transmucosal delivery is now much more than a niche market A niche market also known as a target market is a focused, targetable portion (subset) of a market sector. By definition, then, a business that focuses on a niche market is addressing a need for a product or service that is not being addressed by mainstream providers. within drug delivery. This Report discusses the technologies and drugs currently available for transdermal, buccal buc·cal adj. 1. Of, relating to, adjacent to, or in the direction of the cheek. 2. Of or relating to the mouth cavity. buccal , and intranasal routes of administration. The Report also provides an in-depth analysis of the potential market for transdermal and transmucosal drug delivery. In addition, the intellectual property landscape in this area is summarized, companies invested in transdermal and transmucosal drug delivery are profiled, and key industry players are interviewed. Marketing Opportunities: - Develop new long-lasting transdermal patches transdermal patch: see skin patch. capable of being applied to the skin while administrating the correct dosage of the prescribed drug, thus increasing patient compliance and convenience. - Create transdermal or transmucosal means of delivering low but efficacious ef·fi·ca·cious adj. Producing or capable of producing a desired effect. See Synonyms at effective. [From Latin effic drug concentrations to the target site in order to reduce the potential for product addiction. - Promote products capable of improving patient quality of life and long-term outcomes by controlling plasma drug concentrations. - Salvage drugs with poor pharmacokinetic, pharmacological or toxicity properties when formulated as enterics. - Speed CNS See Continuous net settlement. CNS See continuous net settlement (CNS). active drugs to target through nasal mucosa nasal mucosa, n See mucosa. . Key Reasons to Purchase this report: - Pinpoint the full market potential of transdermal and transmucosal drug delivery systems with an examination of the projected impact through 2010. - Understand the basic concepts behind transdermal and transmucosal drug delivery through a detailed review of the different mucosal sites, transdermal delivery options, and the economic considerations for both. - Compare and contrast existing transdermal and transmucosal drug delivery systems through a detailed overview of the different devices and formulations available. - Gain insight into the markets for transdermal and transmucosal drug delivery through a comprehensive review of the wide-ranging traditional and emerging therapeutic applications. - Discover the current intellectual property landscape via an in-depth review of patents covering transdermal and transmucosal drug delivery. - Look inside 13 companies who are major players in the transdermal and transmucosal drug delivery field, including their product pipelines, partnerships & alliances, business strategies, technologies, and more. The contents of this report are as follows: 1 Introduction 2 Basic Facts and Considerations Concerning Transdermal and Transmucosal Delivery 3 Devices and Formulations 4 Traditional and Emerging Therapeutic Applications and Their Markets 5 Company Profiles - Integrated Developers 6 Company Profiles - The Technology Providers 7 The Transdermal and Transmucosal Market: Overview and Outlook For more information visit http://www.researchandmarkets.com/reports/c8107 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion